These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4635973)

  • 21. Hypo-beta-lipoproteinemic agents. 1. Bicyclo[2.2.2]octyloxyaniline and its derivatives.
    Day CE; Schurr PE; Emmert DE; TenBrink RE; Lednicer D
    J Med Chem; 1975 Nov; 18(11):1065-70. PubMed ID: 170403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lowering of serum lipid levels by "masked" nicotinic acid derivatives.
    Bailey DM; Wood D; Johnson RE; McAuliff JP; Bradford JC; Arnold A
    J Med Chem; 1972 Apr; 15(4):344-8. PubMed ID: 5019547
    [No Abstract]   [Full Text] [Related]  

  • 23. Hypolipidemic activity of 5-aryl-3-methylvaleric acid derivatives.
    Dygos JH; Jett CM; Chinn LJ; Miller JE
    J Med Chem; 1977 Dec; 20(12):1705-8. PubMed ID: 592342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypolipidemic activity of phthalimide derivatives V: Reduced and hydrolytic products of simple cyclic imides.
    Chapman JM; Wyrick SD; Josée Voorstad P; Maguire JH; Cocolas GH; Hall IH
    J Pharm Sci; 1984 Oct; 73(10):1482-4. PubMed ID: 6502502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1-Alkyl-benzotriazole-5-carboxylic acids are highly selective agonists of the human orphan G-protein-coupled receptor GPR109b.
    Semple G; Skinner PJ; Cherrier MC; Webb PJ; Sage CR; Tamura SY; Chen R; Richman JG; Connolly DT
    J Med Chem; 2006 Feb; 49(4):1227-30. PubMed ID: 16480258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypolipidemic activity of phthalimide derivatives. 1. N-Substituted phthalimide derivatives.
    Chapman JM; Cocolas GH; Hall IH
    J Med Chem; 1979 Nov; 22(11):1399-402. PubMed ID: 533887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypocholesterolemic indole-2-carboxylic acids.
    Kariya T; Grisar JM; Wiech NL; Blohm TR
    J Med Chem; 1972 Jun; 15(6):659-62. PubMed ID: 5030934
    [No Abstract]   [Full Text] [Related]  

  • 28. Isonicotinates, nicotinates and clofibrates of N-methyl-N-(2-hydroxyethyl or 3-hydroxypropyl)--1,3,3-trimethylbicyclo [2.2.1]heptan-2-endo-amine with hypocholesterolemic and hypolipidemic activity.
    Bondavalli F; Bruno O; Schenone P; Vacca C; De Carlo R; Marmo E
    Farmaco Sci; 1987 Apr; 42(4):251-7. PubMed ID: 3595837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel phenoxyalkylcarboxylic acid derivatives as hypolipidaemic agents.
    Li W; Jia HY; He XH; Shi WG; Zhong BH
    J Enzyme Inhib Med Chem; 2012 Apr; 27(2):311-8. PubMed ID: 22085137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel thieno oxazine analogues as antihyperglycemic and lipid modulating agents.
    Das SK; Reddy KA; Abbineni C; Iqbal J; Suresh J; Premkumar M; Chakrabarti R
    Bioorg Med Chem Lett; 2003 Feb; 13(3):399-403. PubMed ID: 12565938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analogs of phenothiazines. 5. Synthesis and neuropharmacological activity of some piperidylidene derivatives of thioxanthenes, xanthenes, dibenzoxepins, and acridans.
    Kaiser C; Fowler PJ; Tedeschi DH; Lester BM; Garvey E; Zirkle CL
    J Med Chem; 1974 Jan; 17(1):57-62. PubMed ID: 4808470
    [No Abstract]   [Full Text] [Related]  

  • 32. Potential hypolipidemic agents. 8. 2-Chloro-5-piperidinosulphono-3-thiophenecarboxylic acids.
    Dafgård B; Gronowitz S; Bondesson G; Magnusson O; Stjernström NE
    Acta Pharm Suec; 1974 Jun; 11(3):309-12. PubMed ID: 4839741
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypolipidemic analogues of ethyl 4-benzyloxybenzoate.
    Baggaley KH; Fears R; Hindley RM; Morgan B; Murrell E; Thorne DE
    J Med Chem; 1977 Nov; 20(11):1388-93. PubMed ID: 915898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, and antihyperlipidemic evaluation of novel 2-[1-(substitutedphenyl)-4-oxo-azetidin-2-yl]-5,6-disubstitutedthieno[2,3-d]pyrimidin-4(3H)-ones.
    Arya N; Munde MK; Dwivedi J; Jagdale AY; Jain KS
    Arch Pharm (Weinheim); 2013 Aug; 346(8):588-95. PubMed ID: 23881664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of low molecular weight compounds with complement inhibition activity.
    Master HE; Khan SI; Poojari KA
    Bioorg Med Chem; 2005 Aug; 13(16):4891-9. PubMed ID: 15978815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and quantitative structure-activity relationships of antihyperlipaemic 2-substituted thieno[3,2-d]pyrimidin-4(3H)-ones.
    Shishoo CJ; Jain KS; Rathod IS; Thakkar BJ; Brahmbhatt SB; Gandhi TP; Bangaru R; Goyal RK
    Arzneimittelforschung; 1996 Mar; 46(3):273-6. PubMed ID: 8901148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and cytotoxic activity of substituted 2-phenyl-3-hydroxy-4(1H)-quinolinones-7-carboxylic acids and their phenacyl esters.
    Soural M; Hlavác J; Hradil P; Frysová I; Hajdúch M; Bertolasi V; Malon M
    Eur J Med Chem; 2006 Apr; 41(4):467-74. PubMed ID: 16540209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and hypolipidemic activity of amine-carboxyboranes, and their amides and esters in rodents.
    Sood A; Sood CK; Spielvogel BF; Hall IH; Wong OT; Mittakanti M; Morse K
    Arch Pharm (Weinheim); 1991 Jul; 324(7):423-32. PubMed ID: 1763952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and hypolipidemic activity of modified side chain alpha-asarone homologues.
    Cruz A; Garduño L; Salazar M; Martínez E; Jiménez-Vázquez HA; Díaz F; Chamorro G; Tamariz J
    Arzneimittelforschung; 2001; 51(7):535-44. PubMed ID: 11505784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs.
    Schurr PE; Schultz JR; Parkinson TM
    Lipids; 1972 Jan; 7(1):68-74. PubMed ID: 5013174
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.